Africa News Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Currents.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 30, 2026

Mar. 30, 2026

Alibiu Holdings LLC Releases Second Commentary: 'Why the U.S. and Nigeria Are More Naturally Aligned Than Many Assume'

EIN Presswire

Mar. 30, 2026

Pocfarmer adresse ses félicitations à l’occasion de l’investiture du Président de la République centrafricaine

EIN Presswire

Mar. 30, 2026

Great Adamz Turns Heads at MOBO Awards as Red Carpet Look Trends Online

EIN Presswire

Mar. 30, 2026

FMUSER Customized Hotel IPTV Solution for Cruise Ships and Airplanes

EIN Presswire

Mar. 30, 2026

OR Royalties Files 2025 Year-End Disclosure Documents

GlobeNewswire

Mar. 30, 2026

Redevances OR dépose ses documents d’information de fin d’année 2025

GlobeNewswire

Mar. 30, 2026

Ero Files Technical Report for the Furnas Copper-Gold Project

GlobeNewswire

Mar. 30, 2026

BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

GlobeNewswire

Mar. 30, 2026

Invivyd Announces Presentation at the World Vaccine Congress Washington

GlobeNewswire

Mar. 30, 2026

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

GlobeNewswire

Mar. 30, 2026

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

GlobeNewswire

Mar. 30, 2026

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 30, 2026

Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease

GlobeNewswire

Mar. 30, 2026

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

GlobeNewswire

Mar. 30, 2026

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

GlobeNewswire

Mar. 30, 2026

Top 5 Reasons to Source from a China Leading Baseball Caps provider for Private Label

EIN Presswire

Mar. 30, 2026

Deepvein Mining Technology Unveils DeepSight Exploration, a Robotics-First System for End-to-End Mineral Exploration, in Silicon Valley

GlobeNewswire

Mar. 30, 2026

Tempest Reports Year End 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 30, 2026

Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

GlobeNewswire

Mar. 30, 2026

Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement

GlobeNewswire